MedTrace Logo

Subconjunctiva Bupivacaine as Analgesia in Intravitreal Silicone Oil Removal

NCT03046719 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2017-02-08

No results posted yet for this study

Summary

The study aimed to investigate the effectivity of bupivacaine 0,5% as post-operative analgesia in intravitreal silicone evacutaion surgery

Conditions

  • Retinal Detachment

Interventions

DRUG

Bupivacaine 0,5%

Bupivacaine 0,5% was given on the subconjunctiva, in between stitches by the surgeon after finishing the last stitches

DRUG

NaCl 0,9%

NaCl 0,9% was given on the subconjunctiva, in between stitches by the surgeon after finishing the last stitches

Sponsors & Collaborators

  • Indonesia University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2016-10-31
Completion
2016-12-31

Countries

  • Indonesia

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03046719 on ClinicalTrials.gov